Anchorage Capital Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.5M | Hold |
4,832,642
| – | – | 21.05% | 3 |
|
|
2025
Q1 | $48.8M | Hold |
4,832,642
| – | – | 19.5% | 3 |
|
|
2024
Q4 | $57.2M | Hold |
4,832,642
| – | – | 20.12% | 3 |
|
|
2024
Q3 | $55.8M | Hold |
4,832,642
| – | – | 14.6% | 3 |
|
|
2024
Q2 | $51.1M | Hold |
4,832,642
| – | – | 15.77% | 3 |
|
|
2024
Q1 | $50.9M | Hold |
4,832,642
| – | – | 13.26% | 4 |
|
|
2023
Q4 | $54.3M | Hold |
4,832,642
| – | – | 6.46% | 5 |
|
|
2023
Q3 | $56.4M | Hold |
4,832,642
| – | – | 5.1% | 5 |
|
|
2023
Q2 | $48.7M | Hold |
4,832,642
| – | – | 4.3% | 6 |
|
|
2023
Q1 | $35.7M | Hold |
4,832,642
| – | – | 5.51% | 7 |
|
|
2022
Q4 | $38.6M | Hold |
4,832,642
| – | – | 4.95% | 8 |
|
|
2022
Q3 | $15.6M | Hold |
4,832,642
| – | – | 1.39% | 14 |
|
|
2022
Q2 | $19.7M | Hold |
4,832,642
| – | – | 1.97% | 13 |
|
|
2022
Q1 | $23.9M | Buy |
+4,832,642
| New | +$23.9M | 1.62% | 12 |
|